Andy Johnson has been engaged in pharmaceutical or drug and device litigation throughout his career and has served in organizations concentrating on this specific type of litigation. The firm’s work for this industry includes engagements as national and regional counsel for some of the world’s largest pharmaceutical companies and device manufacturers. Andy has represented Pfizer and Bayer in individual actions as well as multidistrict litigation.

Andy’s work has involved the defense of individual claims, “mass tort” claims, and class actions.

His representative pharmaceutical experience includes:

  • Appointed as co-defense liaison counsel in In Re Chantix (Varenicline) Products LiabilityLitigation MDL 2092.
  • Member of company witness team, preparing and defending company witnesses responsible for clinical trials, pharmacovigilance, and product management in depositions in the U.S. and Europe (see In re Xarelto (Rivaroxaban) Products Liability Litigation, MDL 2592).
  • Member of bellwether trial work-up team, conducting all aspects of case-specific discovery and trial preparation involving pharmaceuticals involved in various consolidated actions in state court and MDL proceedings.
  • Member of expert development teams in various pharmaceutical mass torts for various disciplines, including pharmacovigilance, neurology, psychiatry, hepatology, gastroenterology, pulmonology, cardiology, epidemiology, and FDA regulations and labeling.
  • Member of trial support teams for pharmaceutical cases tried to jury verdict in state and federal courts.
  • Member of marketing and sales representative team for various litigations, developing discovery responses and preparing and defending sales representatives, detail personnel and their managers in depositions.